Table 1. Most effective strategies to teach students to communicate the benefits and risks of medicines Strategy Considered most effective, %

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

Introduction to Drug Information Services Ch.#1. An introductory course to teach the students basic principles of DI retrieval. Designed to help students.
A Pharmacist’s journey: the development of targeted opportunistic multi-disciplinary team training in the treatment of opioid dependence Kevin Foreman.
AESGP Economic Affairs / PR Committee Meeting, Paris, 4-5 November > GREECE Do you believe the pharmacist should act as a health advisor?
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Benton Community Health Center Located at: 530 NW 27 th Street Corvallis, Oregon (inside the Public Services building) Medical Staff consists of: 3 Physicians.
Simon Wills Head of Wessex Drug & Medicines Information Centre Introduction Research is needed to help inform service development and to demonstrate the.
“Do Once and Share” Feedback from the Renal Team B Stribling, K Harris, A Keogh, J Medcalf.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
Drug Information Services. Aims of the Course To introduce the students how to locate, evaluate drug information’s systematically, manage and distribute.
Copyright © 2011 Pearson Education, Inc. All rights reserved. Behavioral Assessment: Initial Considerations Chapter 20.
Simulator of the Hospital Information System for Medical, Public Health, Nursing and Rehabilitation students Project No. VP1-2.2-ŠMM-07-K Lithuanian.
Questions to Committee about Potential Cancer Risk with Use of Topical Immunosuppressants (Calcineurin Inhibitors) Question 1: Messages about Risk A. Based.
Community Resources Assessment Training 2- Community Resources Assessment Training 2-1 Community Resources Assessment Training 2-1.
Developing role of community pharmacy in responding to the needs of people with drug problems Karen Melville Principal Pharmacist TSMS NHS Tayside.
0 © 2015 ADR International The Virtual Supplier Visit This classroom-based simulation leads professionals in procurement, engineering, quality and other.
Planning for Curriculum Framework Implementation.
Angela Binns Barbara Kupke Safety & Facilities Unit Faculty Medicine Nursing & Health Sciences Are Research Higher Degree Candidates Work Health and Safety.
Title of the Change Project
MODULE 15 – ORGANISATIONAL COMMUNICATION
Technical Business Consultancy Project
Good practices abroad / Cyprus case The OiRA implementation
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Patient Focused Drug Development An FDA Perspective
Monitoring and Evaluation Systems for NARS organizations in Papua New Guinea Day 4. Session 12. Risk Management.
Unhealthy Alcohol Use Screening and Interventions
Data Architecture World Class Operations - Impact Workshop.
Risk Communication in Medicines
Medicines Optimisation
Partnering for Successful Outcomes
Malaria - the facts are on the cards.
Learning from 1000 Lives+ Reducing inappropriate use of anti-psychotics in dementia care within care homes Elizabeth Bond, MH Lead pharmacist BCUHB (central)
Development of Inter-Professional Geriatric and Palliative Care Clinic
BUMP IT UP STRATEGY in NSW Public Schools
Lesson 2: SBP Review Lesson 2: SBP Review February 2017
Development of Inter-Professional Geriatric and Palliative Care Clinic
A Continuous Cycle Prospecting Making The Ask Onboarding Mentorship
PARTNERSHIPS WITH CLINICAL SETTINGS: ROLES AND RESPONSIBILITIES OF NURSE EDUCATORS – Chapter 9 –
9/16/2018 The ACT Government’s commitment to Performance and Accountability – the role of Evaluation Presentation to the Canberra Evaluation Forum Thursday,
MOSH Leading Practices Adoption System
Governance and leadership roles for equality and diversity in Colleges
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
CASAS Reports: Assess, Analyze and Adjust
Communication Skills Lecture 1-2
CLICK TO GO BACK TO KIOSK MENU
Grampian COPD MCN Delivering Spirometry in a Community Pharmacy setting, a rural solution? Small I (1,2), Clelland J (1,2), Robertson W (1), Freeman D.
Human Resources Management: Module 2
Reducing Inappropriate Antipsychotic Prescribing
Data Literacy Survey results and Data Protocols
Resource 1. Evaluation Planning Template
Regulatory Responses (n=11) Company Responses (n=20)
What should a decision-maker know?
Regulatory Responses (n=11) Company Responses (n=20)
Behavioral Assessment: Initial Considerations
Assessment Committee Meeting December 15, 2010
Safeguarding Training August 2017
What to do with your data?
Pharmacy practice and the healthcare system Ola Ali Nassr
Pharmaceutical care planning 2 Ola Ali Nassr
Professional Development
What is Project’s Sustainability?
Irish Survey of Student Engagement NCI’s ISSE 2017 data analysed
KEY MESSAGES.
Bullying Prevention Workshops Implementing the Bullying Prevention Guidance The aim of this presentation is to give schools an overview of the bullying.
Communication Plan Template and Example
Univ. Prof Dr Viktor Jakupec
Hospital pharmacy.
The UMBRA Eight-Step Benefit-Risk Framework
TLQAA STANDARDS & TOOLS
Community Benefit Activities
Presentation transcript:

Table 1. Most effective strategies to teach students to communicate the benefits and risks of medicines Strategy Considered most effective, % Faculty (n = 6) Role playing 83% Team-based learning 67% Professional practice laboratory experience Lectures 50% Use of standardized assessment approaches* 33% Understanding the benefit-risk (BR) profile of a medicine is a key aspect of ensuring that the appropriate medicine is being prescribed to the right patient. The FDA and European Medicines Agency have made BR assessment and communication to patients a priority in their long-term strategies. To better understand whether pharmacy students are being prepared for these challenges, we have undertaken a survey of 5th and 6th year students and faculty at 5 pharmacy schools. Participants completed an online pilot survey designed to assess how students are being taught to evaluate the BR profiles of medicines, how BR is being assessed by student pharmacists and how this information is being communicated to their patients during internships. Faculty were asked to select up to three teaching strategies they believed to be the most effective when educating students in how to communicate the benefits and risks associated with a specific therapy (Table 1). A variety of teaching approaches are used by the responding universities. These surveys provide a baseline analysis that can guide pharmacy academia in how to better prepare students in assessing the BR profile of a medicine for a particular patient’s condition. It is the first targeted survey to assess these strategies and to compare differences in how pharmacy school students and faculty perceive their training in BR communication. We believe that these results will form the basis for a more widespread survey and the these and future results can be used to guide a more consistent approach to BR assessment and communication training. From Brown AA. Communicating the benefits and risk of medicines to patients: The pharmacy student’s point of view. Poster presentation; Boston Massachusetts: Annual Meeting of the Drug Information Association, June 2013. *Eg, root-cause analyses, structured benefit-risk assessment/documentation templates. From Brown AA. Communicating the benefits and risk of medicines to patients: The pharmacy student’s point of view. Poster presentation; Boston Massachusetts: Annual Meeting of the Drug Information Association, June 2013.